Seeing Is Believing
Currently out of the existing stock ratings of Liana Moussatos, 247 are a BUY (91.82%), 22 are a HOLD (8.18%).
Analyst Liana Moussatos, carries an average stock price target met ratio of 48.63% that have a potential upside of 40.15% achieved within 355 days. Previously, Liana Moussatos worked at WEDBUSH.
Liana Moussatos’s has documented 513 price targets and ratings displayed on 41 stocks. The coverage was on Healthcare, Technology, Basic Materials, Financial Services sectors.
Most recent stock forecast was given on CLSD, Clearside Biomedical at 12-Mar-2024.
Analyst best performing recommendations are on GRAY (GRAYBUG VISION).
The best stock recommendation documented was for GRAY (GRAYBUG VISION) at 3/9/2021. The price target of $112 was fulfilled within 2 days with a profit of $11.2 (11.11%) receiving and performance score of 55.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Dec-2019
$18
5 years 10 months 7 days ago
(01-Sep-2020)
3/3 (100%)
$3.19 (21.54%)
78
Buy Since 17-Nov-2015
$35
$0.51 (1.48%)
5 years 10 months 7 days ago
(31-Aug-2020)
5/14 (35.71%)
$0.78 (2.28%)
488
Hold Since 04-Feb-2020
$34.5
$0.01 (0.03%)
5 years 10 months 7 days ago
(31-Aug-2020)
5/5 (100%)
$0.28 (0.82%)
138
Buy Since 14-Jun-2016
$34.5
$0.01 (0.03%)
$66
5 years 10 months 7 days ago
(31-Aug-2020)
1/9 (11.11%)
$0.28 (0.82%)
39
Buy Since 03-Jun-2019
$60
5 years 10 months 7 days ago
(31-Aug-2020)
0/19 (0%)
$41.31 (221.03%)
What Year was the first public recommendation made by Liana Moussatos?